Research Study to Evaluate LOTRONEX in Severe IBS-D: Analysis of Current Clinical Practice Environment.
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Alosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Acronyms RELIANCE
- Sponsors Prometheus Laboratories
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record